FDA
Decision support for heart failure care teams
Earlier clinical review and better visibility between visits
Who it serves
Designed for the entire heart failure care continuum.
Cardiology teams
Hospital operations
Health System leadership
The challenge
Traditional cardiac monitoring is invasive, costly, and confined to the hospital
Fragmented Data Systems
Limited Visibility Between Visits
Invasive Procedure Burden
Workflow fit
Coredio supports care teams from hospital to home without adding workflow fragmentation.
Personalization
Impact
Clinical and financial value for hospital systems.
~50%
Projected readmission reduction (based on comparables)
6 to 10x
Projected hospital ROI from improved quality metrics
Workflow
Disruption minimized with device-agnostic approach
Spot check
Visibility between visits, in clinic and at home
The solution
Coredio brings catheter-grade hemodynamics to anywhere
LVDEP
Left Ventricular End-Diastolic Pressure (LVEDP) predicts worsening heart failure before symptoms start.
Frequently asked questions
No. Coredio is entirely noninvasive. It relies on wearable sensors such as a smartwatch and a blood-pressure cuff — there are no implants, catheters, or surgical procedures involved.
Every heart is different. Coredio builds a model from your own baseline measurements, then tracks your individual cardiovascular trends over time and shares them with your clinician. The aim is earlier, smarter intervention before a small change becomes a serious one.
A compatible smartwatch and a blood-pressure cuff. If you don't already have a watch, we'll provide one as part of your home setup.
Coredio is designed for clinicians managing heart-failure patients and for the patients themselves who benefit from continuous, at-home hemodynamic monitoring.
Connect
with Coredio team!
Join the clinicians who are exploring the future of cardiovascular monitoring
